Avise Analytics is the fastest growing equity research firm that authors institutional quality equity research reports, with special focus on Nano-Cap and Micro-Cap companies that are undervalued and lacks adequate coverage.
Our team of highly experienced analysts provides a wide range of tailored services in the field of equity, investment and financial research and investor relations to our diversified client base around the world.
Our free mobile app gives you real-time notifications on publication of short company stories for compelling investment ideas so that you never miss an opportunity!
As a step to effectively handle your research team’s workload as a business partner, our free mobile (and tablet friendly) application, also offer you a complete accessibility in tracking your project progress and billing and payment status at the tip of your finger any time.
Download the app for free now to explore our talent pool and feel the difference in outsourcing your work to us.
We pride ourselves in constantly delivering high-quality and scalable equity, investment and credit research solutions to our diversified client base across 9 countries. A snapshot of our key experience in past 3 years includes:
Conformis Inc (NASDAQ: CFMS), a medical technology company dealing in Knee and Joint replacements, has announced the cle...12 November, 2019No comment
Forewarn, Red Violet Company (NASDAQ: RDVT), a leading consumer insight solution provider, announced that it has entered...11 November, 2019No comment
KushCo Holdings (OTCQX: KSHB), a leading player in the Cannabis-based ancillary industry, announced its foray into Hemp ...08 November, 2019No comment
Enlivex Therapeutics (NASDAQ: ENLV), a Company focused on developing allogenic therapies for immune system rebalancing, ...07 November, 2019No comment
Cyclerion Therapeutics (NASDAQ: CYCN), a clinical-stage Company, announced the failure of its drug candidate praliciguat...06 November, 2019No comment
Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig’s disease is a progressive neurodegenerative disease, characterized ...05 November, 2019No comment
Infinera (NASDAQ: INFN), a leading optical transmission solution provider, announced that its 7300 Multi-haul Transport ...04 November, 2019No comment
Medicinova (NASDAQ: MNOV), a Company developing small molecule therapeutics, has received notice of allowances for grant...01 November, 2019No comment
Provention Bio (NASDAQ: PRVB), a clinical-stage biopharmaceutical Company, announced the grant of a PRIority MEdicines (...31 October, 2019No comment
The Global legal marijuana market is likely to reach over USD 66.3 billion by the end of 2025, as per a report by Grand ...30 October, 2019No comment
dynaCERT (OTCQB: DYFSF), a Company dealing in transportable hydrogen generator aftermarket products, announced the signi...25 October, 2019No comment
Pompe disease is characterized by the build-up of complex sugars named glycogens in the body’s cell, due to the lack o...24 October, 2019No comment
Paratek Pharmaceuticals (NASDAQ: PRTK), a commercial-stage biopharmaceutical Company, announced the withdrawal of its su...23 October, 2019No comment
HLS Therapeutics Inc (OTCPINK: HLTRF), a specialty pharmaceutical Company developing solutions for the treatment of cent...22 October, 2019No comment
Kandi Technologies Group Inc (NASDAQ: KNDI), a Company engaged in the development and manufacturing of vehicular product...21 October, 2019No comment
Avise Analytics is a professionally managed organization and understood job scopes & requirements very well. The report and analysis generated meet my expectations and will not hesitate to recommend others.
Delivered a high-quality set of documents that exceeded my expectations. Keep up the good work!!
Great team. We ramped up our coverage universe quickly due to their help. I highly recommend them!
High quality equity research provider that we now use for regular work
Excellent communication skills and a high commitment to client satisfaction.
Instrumental in helping us complete the research in such a tight timeline!
I have found Avise Analytics to be a great, cost-effective solution to providing both simple and complex finance-related articles for various blogs and newsletters. They are detailed oriented, consciences, respond well to direction, prompt and really know the finance industry.